RT Journal Article
SR Electronic
T1 No benefit from mirtazapine for treating agitation in dementia
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 68
OP 68
DO 10.1136/dtb.2022.000013
VO 60
IS 5
YR 2022
UL http://dtb.bmj.com/content/60/5/68.abstract
AB Review of: Banerjee S, High J, Stirling S, et al. Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial. Lancet 2021;398:1487–97.